| 2026 |
Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2026). Response to “Letter to the editor regarding: “Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression” by Nguyen et al. (2025)”. Journal of Affective Disorders, 394(Pt A), 2 pages. DOI |
| 2026 |
Paris, J., Laurendi, O., Arnet, V., & Galletly, C. (2026). Cannabis use and cardiometabolic risk in schizophrenia. Schizophrenia Research, 287, 54-62. DOI |
| 2026 |
Suetani, S., Dark, F., Every-Palmer, S., Galletly, C., O’Donoghue, B., Halstead, S., . . . Siskind, D. (2026). Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia. Australian and New Zealand Journal of Psychiatry, 60(4 Special Issue: Schizophrenia Guidelines), 367-404. DOI |
| 2026 |
Suetani, S., Galletly, C., Lawn, S., & Siskind, D. (2026). New guidelines for management of schizophrenia in Australia and Aotearoa New Zealand. Australian and New Zealand Journal of Psychiatry, 60(4 Special Issue: Schizophrenia Guidelines), 305-307. DOI |
| 2025 |
Sharmil, H., Galletly, C., Kelly, J., Wilkes, T., George, A., Jaison, M., . . . Annamalai, K. (2025). Awareness of access to health care: a significant need of the Narikuravar people, India. Rural and Remote Health, 25(4), 7 pages. DOI |
| 2025 |
Christodoulou, V., Liu, D., Esterman, A., & Galletly, C. (2025). 'Facilitators and barriers to recruitment in mental health research: A survey of psychiatrists and psychiatry registrars in training'. Australasian Psychiatry, 33(1), 153-161. DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2025). Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression. Journal of Affective Disorders, 385, 11 pages. DOI Scopus2 WoS2 |
| 2025 |
Gill, S., & Galletly OAM, C. (2025). ‘I, robot, can help you’. Applications of Generative Artificial Intelligence in RANZCP psychiatry training. Australasian Psychiatry, 33(4), 689-692. DOI Scopus1 WoS1 |
| 2025 |
Halstead, S., Yap, C. X., Warren, N., Agarwal, S. M., Brand, B. A., Chan, S. K. W., . . . McCutcheon, R. A. (2025). Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission. Lancet Psychiatry, 12(9), 673-699. DOI Scopus7 Europe PMC2 |
| 2025 |
Burford, C., Proctor, J., Thomson, S., Toh, J., Schubert, K. O., & Galletly, C. (2025). Clinical characteristics of people referred for Medicare Item 291 Psychiatric Assessments in northern metropolitan Adelaide. Australasian Psychiatry, 33(6), 916-922. DOI |
| 2025 |
Galletly, C. (2025). Antipsychotic augmentation of clozapine. Australasian Psychiatry, 33(2), 303. DOI Scopus1 WoS1 |
| 2024 |
Galbally, M., Kotze, B., Bell, C., Quadrio, C., Galletly, C., Herrman, H., . . . Morgan, S. (2024). Achieving gender equity in academic psychiatry – barriers to involvement and solutions for success. Australasian Psychiatry, 32(6), 563-567. DOI Scopus2 Europe PMC1 |
| 2024 |
Weickert, T. W., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W. S., . . . Shannon Weickert, C. (2024). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, Behavior, and Immunity, 115, 191-200. DOI Scopus28 WoS23 Europe PMC24 |
| 2024 |
Weickert, T. W., Ji, E., Galletly, C., Boerrigter, D., Morishima, Y., Bruggemann, J., . . . Kindler, J. (2024). Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning. Schizophrenia Bulletin, 50(2), 403-417. DOI Scopus9 WoS9 Europe PMC8 |
| 2024 |
Tran, L., Hahn, L., Gill, S., Ng, F., Clarke, P., Paterson, T., & Galletly, C. (2024). Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry, 32(3), 180-185. DOI Scopus5 WoS2 Europe PMC1 |
| 2023 |
Arnautovska, U., Vitangcol, K., Kesby, J. P., Warren, N., Rossell, S. L., Neill, E., . . . Siskind, D. (2023). Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study. Schizophrenia Research: Cognition, 33, 100283-1-100283-7. DOI Scopus8 |
| 2023 |
Lindell‐Innes, R., Phillips‐Hughes, A. L., Bartsch, D., Galletly, C., & Ludbrook, C. (2023). Attitudes of psychiatry trainees towards patients with borderline personality disorder: Does the stigma begin during training?. Personality and Mental Health, 17(4), 387-395. DOI Scopus14 WoS14 Europe PMC8 |
| 2022 |
Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2022). Associations between health literacy, cognitive function and general literacy in people with schizophrenia attending community mental health clinics in Australia.. BMC Psychiatry, 22(1), 9 pages. DOI Scopus7 WoS7 Europe PMC6 |
| 2022 |
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Benyamin, B., & O'Donovan, M. C. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508. DOI Scopus1807 WoS1729 Europe PMC2176 |
| 2022 |
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hahn, L., Lavale, A., . . . Fitzgerald, P. B. (2022). Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes?. Brain Stimulation, 15(4), 889-891. DOI Scopus4 WoS3 Europe PMC2 |
| 2022 |
Sigrist, C., Vöckel, J., MacMaster, F. P., Farzan, F., Croarkin, P. E., Galletly, C., . . . Koenig, J. (2022). Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. European Child and Adolescent Psychiatry, 31(10), 1501-1525. DOI Scopus52 Europe PMC32 |
| 2022 |
Neill, E., Rossell, S. L., Yolland, C., Meyer, D., Galletly, C., Harris, A., . . . Castle, D. J. (2022). N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin, 48(6), 1263-1272. DOI Scopus27 WoS25 Europe PMC22 |
| 2022 |
Condon, J., Stewart, C., & Galletly, C. (2022). Is PTSD a Bodily Injury?. Journal of Law and Medicine, 29(3), 888-894. |
| 2022 |
Nguyen, H., Haeney, O., & Galletly, C. (2022). The characteristics of older homicide offenders: a systematic review. Psychiatry, Psychology and Law, 29(3), 413-430. DOI Scopus8 WoS8 Europe PMC2 |
| 2022 |
Ji, E., Boerrigter, D., Cai, H. Q., Lloyd, D., Bruggemann, J., O'Donnell, M., . . . Shannon Weickert, C. (2022). Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain, Behavior, and Immunity, 101, 423-434. DOI Scopus32 WoS29 Europe PMC30 |
| 2022 |
Amir Izzat, J., Cherrie, G., & Nick, F. (2022). Improving services for those who serve: A private practice initiative to improve psychiatric care for first responder and military patients. Australasian Psychiatry, 30(3), 103985622110578. DOI |
| 2022 |
Fitzgerald, P. B., Gill, S., Breakspear, M., Kulkarni, J., Chen, L., Pridmore, S., . . . Hoy, K. E. (2022). Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Australian & New Zealand Journal of Psychiatry, 56(8), 905-909. DOI Scopus9 WoS10 Europe PMC5 |
| 2022 |
Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C., . . . Galletly, C. (2022). The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review. Biomedicine and Pharmacotherapy, 146, 18 pages. DOI Scopus49 WoS42 Europe PMC34 |
| 2022 |
Murphy, C. E., Walker, A. K., O’Donnell, M., Galletly, C., Lloyd, A. R., Liu, D., . . . Weickert, T. W. (2022). Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Translational Psychiatry, 12(1), 11 pages. DOI Scopus32 WoS30 Europe PMC28 |
| 2022 |
Galletly, C. A. (2022). Effective family interventions for people with schizophrenia. Lancet Psychiatry, 9(3), 185-187. DOI Scopus4 WoS3 Europe PMC3 |
| 2021 |
Giam, A., Chen, L., Lisa Hahn., Gill, S., Clarke, P., Ng, F., . . . Fitzgerald, P. (2021). Comparing theta burst stimulation with standard left high frequency transcranial magnetic stimulation in the treatment of depression in a randomized controlled study: A preliminary comparison study. Journal of Affective Disorders Reports, 5, 100162-1-100162-7. DOI Scopus7 |
| 2021 |
Arnautovska, U., Neill, E., Rossell, S. L., Yolland, C., Galletly, C., Harris, A., . . . Siskind, D. (2021). Does the clozapine/norclozapine ratio predict cognitive performance in patients with clozapine-resistant schizophrenia?. Australian and New Zealand Journal of Psychiatry, 56(7), 875-878. DOI Scopus6 WoS6 Europe PMC5 |
| 2021 |
Ford, H., Hahn, L., Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2021). A comparison of 15 minute vs 30 minute repetitive transcranial magnetic stimulation sessions for treatment resistant depression – are longer treatment sessions more effective?. Journal of Affective Disorders, 282, 974-978. DOI Scopus4 WoS4 Europe PMC3 |
| 2021 |
Galletly, C., Suetani, S., Hahn, L., McKellar, D., & Castle, D. (2021). Ageing with psychosis – Fifty and beyond. Australian & New Zealand Journal of Psychiatry, 56(1), 39-49. DOI Scopus4 WoS4 Europe PMC3 |
| 2021 |
Bampton, T. J., Hack, D., & Galletly, C. A. (2021). Clozapine treatment for Huntington's disease psychosis.. The Australian and New Zealand journal of psychiatry, 56(2), 48674211013082. DOI Scopus8 WoS4 Europe PMC3 |
| 2021 |
Enticott, P. G., Barlow, K., Guastella, A. J., Licari, M. K., Rogasch, N. C., Middeldorp, C. M., . . . Fitzgerald, P. B. (2021). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open, 11(7), e046830-1-e046830-9. DOI Scopus18 WoS17 Europe PMC15 |
| 2021 |
Sharmil, H., Kelly, J., Bowden, M., Galletly, C., Cairney, I., Wilson, C., . . . de Crespigny, C. (2021). Participatory Action Research-Dadirri-Ganma, using Yarning: methodology co-design with Aboriginal community members. International Journal for Equity in Health, 20(1), 160-1-160-11. DOI Scopus59 WoS44 Europe PMC26 |
| 2021 |
Chen, L., Thomas, E. H., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial. Brain Stimul, 14(5), 1095-1105. DOI Scopus84 WoS76 Europe PMC68 |
| 2021 |
Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Corrigendum to, 'Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial' [Brain Stimulat. 14(5) (2021) 1095-1105].. Brain stimulation, 14(5), 1218. DOI |
| 2021 |
Jernbom Falk, A., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2021). Autoantibody profiles associated with clinical features in psychotic disorders. Translational Psychiatry, 11(1), 1-9. DOI Scopus26 WoS26 Europe PMC26 |
| 2020 |
Galletly, C., Ash, D., Sweeney, S., O'Neill, F., & Crichton, J. (2020). Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder.. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 28(2), 193-198. DOI WoS1 |
| 2020 |
Ji, E., Weickert, C. S., Purves-Tyson, T., White, C., Handelsman, D. J., Desai, R., . . . Weickert, T. W. (2020). Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia. Psychoneuroendocrinology, 123, 104916. DOI Scopus14 WoS12 Europe PMC9 |
| 2020 |
Galletly, C. (2020). A Whale of an issue.. Aust N Z J Psychiatry, 54(11), 1053-1055. DOI |
| 2020 |
Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C., . . . Rossell, S. L. (2020). Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutritional Neuroscience, 23(2), 139-148. DOI Scopus39 WoS33 Europe PMC31 |
| 2020 |
Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O Donnell, M., . . . Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25(4), 761-775. DOI Scopus188 WoS180 Europe PMC166 |
| 2020 |
Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2020). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study.. JMIR mental health, 7(1), e11551. DOI Scopus21 WoS19 Europe PMC17 |
| 2020 |
Zulfic, Z., Weickert, C. S., Weickert, T. W., Liu, D., Myles, N., & Galletly, C. (2020). Neutrophil-lymphocyte ratio - a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders?. Australas Psychiatry, 28(4), 454-458. DOI Scopus43 WoS38 Europe PMC34 |
| 2020 |
Myles, H., Myles, N., Vincent, A. D., Wittert, G., Adams, R., Chandratilleke, M., . . . Galletly, C. (2020). Pilot cohort study of obstructive sleep apnoea in community-dwelling people with schizophrenia.. Ir J Psychol Med, 38(1), 1-7. DOI Scopus5 WoS7 Europe PMC5 |
| 2020 |
Galletly, C. (2020). Psychiatry in the COVID-19 Era. Australian and New Zealand Journal of Psychiatry, 54(5), 447-448. DOI Scopus21 Europe PMC15 |
| 2020 |
Siskind, D., Northwood, K., Berk, M., Castle, D., Galletly, C., & Harris, A. (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. Australian and New Zealand Journal of Psychiatry, 54(7), 759-761. DOI Scopus2 Europe PMC2 |
| 2020 |
Cai, H. Q., Weickert, T. W., Catts, V. S., Balzan, R., Galletly, C., Liu, D., . . . Shannon Weickert, C. (2020). Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain, Behavior, and Immunity, 89, 200-208. DOI Scopus29 WoS27 Europe PMC25 |
| 2020 |
Clifford, L., Crabb, S., Turnbull, D., Hahn, L., & Galletly, C. (2020). A qualitative study of medication adherence amongst people with schizophrenia. Archives of Psychiatric Nursing, 34(4), 194-199. DOI Scopus27 WoS25 Europe PMC18 |
| 2020 |
Plevin, D., & Galletly, C. (2020). The neuropsychiatric effects of vitamin C deficiency: a systematic review.. BMC Psychiatry, 20(1), 1-9. DOI Scopus97 WoS76 Europe PMC59 |
| 2020 |
Thomson, S., Doan, T., Liu, D., Schubert, K. O., Toh, J., Boyd, M. A., & Galletly, C. (2020). Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australasian Psychiatry, 28(5), 492-499. DOI Scopus14 WoS14 Europe PMC13 |
| 2020 |
Galletly, C. (2020). Sexual misconduct by doctors: a problem that has not gone away. Medical Journal of Australia, 213(5), 216-217. DOI Scopus2 WoS3 |
| 2020 |
Henderson, S., Berk, M., Boyce, P., Jorm, A., Galletly, C., Porter, R., . . . Malhi, G. (2020). Finding reviewers: A crisis for journals and their authors. Australian and New Zealand Journal of Psychiatry, 54(10), 957-959. DOI Scopus6 WoS3 Europe PMC2 |
| 2019 |
Balzan, R. P., Mattiske, J. K., Delfabbro, P., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial.. Schizophrenia bulletin, 45(1), 27-36. DOI Scopus34 WoS33 Europe PMC27 |
| 2019 |
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., . . . Stubbs, B. (2019). The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry, 6(8), 675-712. DOI Scopus1259 WoS1191 Europe PMC1002 |
| 2019 |
Firth, J., Rosenbaum, S., Galletly, C., Siddiqi, N., Stubbs, B., Killackey, E., . . . Siskind, D. (2019). Protecting physical health in people with mental illness – Authors' reply. The Lancet Psychiatry, 6(11), 890-891. DOI Scopus19 WoS8 Europe PMC9 |
| 2019 |
Galletly, C. (2019). More access for some but not others: Is it better?. Australian and New Zealand Journal of Psychiatry, 53(11), 1041-1043. DOI Scopus1 Europe PMC1 |
| 2019 |
Szabo, S., Lloyd, B., McKellar, D., Myles, H., Newton, H., Schutz, J., . . . Galletly, C. (2019). ‘Having a mentor helped me with difficult times’: a trainee-run mentoring project. Australasian Psychiatry, 27(3), 230-233. DOI Scopus14 WoS13 Europe PMC7 |
| 2019 |
Galletly, C. A., & Xinhui, L. (2019). To suit the occasion, I wore my fancy dress.. Australasian Psychiatry. |
| 2019 |
Szabo, S., Lloyd, B., McKellar, D., Newton, H., Shutz, J., Hahn, L., & Galletly, C. (2019). 'Having a mentor helped me with difficult times:' a trainee-run mentoring project.. Australasian Psychiatry, 27(3), 230-233. |
| 2019 |
Balzan, R., Delfabbro, P., Mattiske, J., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A randomised Clinical Trial.. Schizophrenia Bulletin, 45(1), 27-36. |
| 2019 |
Galletly, C. (2019). Paracetamol, pregnancy and public health. Australian and New Zealand Journal of Psychiatry, 53(3), 181-183. DOI |
| 2019 |
Myles, N., Myles, H., Xia, S., Large, M., Bird, R., Galletly, C., . . . Siskind, D. (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian and New Zealand Journal of Psychiatry, 53(5), 403-412. DOI Scopus70 WoS64 Europe PMC52 |
| 2019 |
Lim, X., & Galletly, C. (2019). “To suit the occasion, I wore my schizophrenic fancy dress” – the life of Janet Frame. Australasian Psychiatry, 27(5), 1039856219839489. DOI Scopus2 WoS1 |
| 2019 |
Clarke, E., Clarke, P., Gill, S., Paterson, T., Hahn, L., & Galletly, C. (2019). Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders.. Journal of affective disorders, 252, 435-439. DOI Scopus61 WoS50 Europe PMC43 |
| 2019 |
Owens, S. J., Weickert, T. W., Purves-Tyson, T. D., Ji, E., White, C., Galletly, C., . . . Shannon Weickert, C. (2019). Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.. Molecular neuropsychiatry, 5(1), 28-41. DOI Europe PMC2 |
| 2019 |
Weickert, C. S., Lee, C. H., Lenroot, R. K., Bruggemann, J., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia. Schizophrenia Research, 209, 212-217. DOI Scopus14 WoS14 Europe PMC12 |
| 2019 |
Lee, C. H., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. W. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research, 213, 87-95. DOI Scopus16 WoS15 Europe PMC9 |
| 2019 |
Kindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 43(11), 13 pages. DOI Scopus229 WoS214 Europe PMC202 |
| 2019 |
Turner, S., Harvey, C., Hayes, L., Castle, D., Galletly, C., Sweeney, S., . . . Spittal, M. J. (2019). Childhood adversity and clinical and psychosocial outcomes in psychosis. Epidemiology and Psychiatric Sciences, 29, e78. DOI Scopus52 WoS47 Europe PMC33 |
| 2019 |
Myles, H., Myles, N., Coetzer, C. L. C., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2019). Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: a pilot study. Schizophrenia Research: Cognition, 15, 14-20. DOI Scopus20 WoS17 Europe PMC14 |
| 2018 |
Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2018). Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?. Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders, 12(6), 1045-1051. DOI Scopus8 WoS7 Europe PMC6 |
| 2018 |
Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2018). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study (Preprint). DOI |
| 2018 |
Galletly, C., & Myles, H. (2018). Making an impact. Australian and New Zealand Journal of Psychiatry, 52(8), 725-726. DOI Scopus1 Europe PMC1 |
| 2018 |
Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., O'Donnell, M., Lenroot, R., . . . Weickert, T. (2018). C-Reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9(OCT), 2230-1-2230-16. DOI Scopus91 WoS86 Europe PMC87 |
| 2018 |
Rosenich, E., Gill, S., Clarke, P., Paterson, T., Hahn, L., & Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants?. Early Intervention in Psychiatry, 13(5), 1-7. DOI Scopus19 WoS14 Europe PMC14 |
| 2018 |
Galletly, C., Suetani, S., & Dark, F. (2018). Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52(9), 819-821. DOI Scopus3 WoS3 Europe PMC1 |
| 2018 |
Haeney, O., Ash, D., & Galletly, C. (2018). School Shootings – ‘It wouldn’t happen here’?. Australian and New Zealand Journal of Psychiatry, 52(5), 405-407. DOI Scopus2 WoS2 Europe PMC1 |
| 2018 |
Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 26(6), 600-603. DOI Scopus20 WoS14 Europe PMC12 |
| 2018 |
Myles, N., Myles, H., Xia, S., Large, M., Kisely, S., Galletly, C., . . . Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta psychiatrica Scandinavica, 138(2), 101-109. DOI Scopus189 Europe PMC142 |
| 2018 |
Balzan, R. P., Dhillon, V. S., Liu, D., Hahn, L., Fenech, M. F., & Galletly, C. (2018). Shorter telomere length in people with schizophrenia who live alone?. Schizophrenia Research, 199, 422-423. DOI Scopus6 WoS4 Europe PMC3 |
| 2018 |
Campbell, L., Hanlon, M. -C., Galletly, C., Harvey, C., Stain, H., Cohen, M., . . . Brown, S. (2018). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52(5), 435-445. DOI Scopus25 WoS26 Europe PMC20 |
| 2018 |
Koblar, S., Cranwell, M., Koblar, S., Carnell, B., & Galletly, C. (2018). Developing empathy: does experience through simulation improve medical student empathy?. Medical Science Educator, 28(1), 31-36. DOI Scopus17 |
| 2017 |
Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., Liu, D., . . . Weickert, C. (2017). Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. Journal of Neuroinflammation, 14(1), 188-1-188-15. DOI Scopus147 WoS141 Europe PMC132 |
| 2017 |
Galletly, C. A. (2017). Psychiatry training: survive and thrive. Medical Journal of Australia, 206(11), 485. DOI |
| 2017 |
Galletly, C. (2017). Risks, benefits and finding the best way forward. Australian and New Zealand Journal of Psychiatry, 51(10), 963-964. DOI |
| 2017 |
Castle, D. J., Galletly, C. A., Dark, F., Humberstone, V., Morgan, V. A., Killackey, E., . . . Jablensky, A. (2017). The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. Medical Journal of Australia, 206(11), 501-505. DOI Scopus25 WoS26 Europe PMC21 |
| 2017 |
Glass, L., Sinclair, D., Boerrigter, D., Naude, K., Fung, S., Brown, D., . . . Shannon Weickert, C. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Translational Psychiatry, 7(8), 1-9. DOI Scopus19 WoS20 Europe PMC18 |
| 2017 |
Jablensky, A., Castle, D. J., Dark, F., Humberstone, V., Killackey, E., Kulkarni, J., . . . Galletly, C. (2017). The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders – what’s next?. Australasian Psychiatry, 25(6), 600-602. DOI Scopus7 WoS7 Europe PMC7 |
| 2017 |
Groenkjaer, M., de Crespigny, C., Liu, D., Moss, J., Cairney, I., Lee, D., . . . Galletly, C. (2017). "The chicken or the egg": barriers and facilitators to collaborative care for people with comorbidity in a metropolitan region of South Australia. Issues in Mental Health Nursing, 38(1), 18-24. DOI Scopus14 WoS13 Europe PMC12 |
| 2017 |
Galletly, C. A., Carnell, B. L., Clarke, P., & Gill, S. (2017). A comparison of right unilateral and sequential bilateral repetitive transcranial magnetic stimulation for major depression: a naturalistic clinical Australian study. Journal of ECT, 33(1), 58-62. DOI Scopus11 WoS11 Europe PMC8 |
| 2017 |
Myles, N., Large, M., Myles, H., Adams, R., Liu, D., & Galletly, C. (2017). Australia's economic transition, unemployment, suicide and mental health needs. Australian and New Zealand Journal of Psychiatry, 51(2), 119-123. DOI Scopus15 WoS13 Europe PMC12 |
| 2017 |
Allison, S., Bastiampillai, T., Galletly, C., & Nance, M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry.. Australian and New Zealand Journal of Psychiatry, 51(8), 1. DOI |
| 2017 |
Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4(4), 263-265. DOI Scopus24 WoS21 Europe PMC18 |
| 2017 |
Hahn, L. A., Mackinnon, A., Foley, D. L., Morgan, V. A., Waterreus, A., Watts, G. F., . . . Galletly, C. A. (2017). The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis. Schizophrenia Research, 184, 88-95. DOI Scopus3 WoS3 Europe PMC1 |
| 2017 |
Morgan, V., Waterreus, A., Carr, V., Castle, D., Cohen, M., Harvey, C., . . . Galletly, C. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51(2), 124-140. DOI Scopus104 WoS94 Europe PMC72 |
| 2017 |
Smith, C., Myles, H., & Galletly, C. (2017). Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk. Australasian Psychiatry, 25(4), 387-390. DOI Scopus4 WoS4 Europe PMC3 |
| 2017 |
Carnell, B. L., Clarke P., Gill, S., Galletly, C. A., & Galletly, C. A. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression?. The Journal of Affective Disorders, 209, 270-272. DOI Scopus19 WoS16 Europe PMC14 |
| 2017 |
Galletly, C., Dhillon, V. S., Liu, D., Balzan, R. P., Hahn, L. A., & Fenech, M. F. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51. DOI Scopus18 WoS17 Europe PMC18 |
| 2017 |
Posselt, M., McDonald, K., Procter, N., De Crespigny, C., & Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1), 280-1-280-17. DOI Scopus52 WoS51 Europe PMC31 |
| 2017 |
Large, M., Galletly, C., Myles, N., Ryan, C. J., & Myles, H. (2017). Known unknowns and unknown unknowns in suicide risk assessment: Evidence from meta-analyses of aleatory and epistemic uncertainty. Bjpsych Bulletin, 41(3), 160-163. DOI Scopus34 Europe PMC20 |
| 2017 |
Nielssen, O., McGorry, P., Castle, D., & Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: why is our practice so far short of our recommendations, and what can we do about it?. Australian and New Zealand Journal of Psychiatry, 51(7), 670-674. DOI Scopus7 WoS6 Europe PMC7 |
| 2017 |
Siskind, D., Harris, M., Phillipou, A., Morgan, V., Waterreus, A., Galletly, C., . . . Castle, D. (2017). Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. Epidemiology and psychiatric sciences, 26(3), 325-337. DOI Scopus27 WoS25 Europe PMC25 |
| 2017 |
Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2017). The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophrenia Research, 182, 13-18. DOI Scopus3 WoS3 Europe PMC2 |
| 2017 |
Kulkarni, J., & Galletly, C. A. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51(2), 192-194. DOI Scopus11 WoS8 Europe PMC10 |
| 2017 |
Myles, H., Myles, N., Liu, D., Adams, R., Wittert, G., Antic, N. A., & Galletly, C. (2017). How long will we sleep on obstructive sleep apnoea in schizophrenia?. Australian & New Zealand Journal of Psychiatry, 51(1), 95-96. DOI Scopus3 WoS3 Europe PMC2 |
| 2016 |
Large, M., Galletly, C. A., Myles, N., Ryan, C. J., & Myles, H. (2016). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJPsych Bulletin. |
| 2016 |
Weinberg, D., Lenroot, R., Jacomb, I., Allen, K., Bruggemann, J., Wells, R., . . . Weickert, T. (2016). Cognitive subtypes in schizophrenia characterized by differential brain volumetric reductions and cognitive decline. JAMA Psychiatry, 73(12), 1251-1259. DOI Scopus86 WoS84 Europe PMC79 |
| 2016 |
Liu, D., Myles, H., Foley, D., Watts, G., Morgan, V., Castle, D., . . . Galletly, C. (2016). Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health. Frontiers in Psychiatry, 7(AUG), 139-1-139-12. DOI Scopus18 WoS13 Europe PMC9 |
| 2016 |
Morgan, V., Morgan, F., Galletly, C., Valuri, G., Shah, S., & Jablensky, A. (2016). Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology, 51(2), 269-279. DOI Scopus23 WoS20 Europe PMC19 |
| 2016 |
Myles, H., Myles, N., Antic, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2016). Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophrenia Research, 170(1), 222-225. DOI Scopus66 WoS52 Europe PMC46 |
| 2016 |
Galletly, C., Clark, L., McFarlane, A., Searle, A., Sawyer, M., Sim, M., . . . van Hooff, M. (2016). Childhood lead exposure, childhood trauma, substance use and subclinical psychotic experiences - a longitudinal cohort study. Psychiatry Research, 239, 54-61. DOI Scopus5 WoS5 |
| 2016 |
Galletly, C., Turnbull, C., & Goldney, R. (2016). Medical student teaching in the private sector - An overlooked opportunity?. Australasian Psychiatry, 24(2), 198-200. DOI Scopus4 WoS3 Europe PMC2 |
| 2016 |
Galletly, C. A., Gill, S., Rigby, A., Carnell, B. L., & Clarke, P. (2016). Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing. Journal of ECT, 32(3), 169-173. DOI Scopus12 WoS11 Europe PMC9 |
| 2016 |
Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50(5), 410-472. DOI Scopus752 WoS689 Europe PMC544 |
| 2016 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Awareness of pre-diabetes or diabetes and associated factors in people with psychosis. Schizophrenia Bulletin, 42(5), 1280-1289. DOI Scopus13 WoS11 Europe PMC6 |
| 2016 |
Liu, D., de Crespigny, C., Procter, N., Kelly, J., Francis, H., Posselt, M., . . . Galletly, C. A. (2016). Comorbidity action in the north – a study of services for people with comorbid mental health and drug and alcohol disorders in the northern suburbs of Adelaide. Australasian Psychiatry, 24(6), 592-597. DOI Scopus12 WoS12 Europe PMC9 |
| 2016 |
Suetani, S., Waterreus, A., Morgan, V., Foley, D., Galletly, C., Badcock, J., . . . McGrath, J. (2016). Correlates of physical activity in people living with psychotic illness. Acta Psychiatrica Scandinavica, 134(2), 129-137. DOI Scopus45 WoS39 Europe PMC36 |
| 2016 |
Cohen, O., Weickert, T., Hess, J., Paish, L., McCoy, S., Rothmond, D., . . . Glatt, S. (2016). A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Molecular Psychiatry, 21(7), 975-982. DOI Scopus32 WoS23 Europe PMC24 |
| 2016 |
Galletly, C. (2016). Compulsive reading: Stars with addictions, to Star Wars. Australian and New Zealand Journal of Psychiatry, 50(8), 713-715. DOI |
| 2016 |
Waterreus, A., Di Prinzio, P., Watts, G., Castle, D., Galletly, C., & Morgan, V. (2016). Metabolic syndrome in people with a psychotic illness: Is cannabis protective?. Psychological Medicine, 46(8), 1651-1662. DOI Scopus22 Europe PMC20 |
| 2016 |
Foley, D., Mackinnon, A., Morgan, V., Castle, D., Waterreus, A., Galletly, C., & Galletly, C. (2016). Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis. Schizophrenia Bulletin, 44(1), 9 pages. DOI Scopus14 WoS12 Europe PMC11 |
| 2016 |
Sweeney, S., Air, T., Zannettino, L., Shah, S. S., & Galletly, C. (2016). Corrigendum: Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis [Front. Psychol, 6, (2015):(1768)] Doi: 10.3389/fpsyg.2015.01768. Frontiers in Psychology, 7(AUG), 2 pages. DOI Scopus1 WoS2 Europe PMC1 |
| 2016 |
Rossell, S., Francis, P., Galletly, C., Harris, A., Siskind, D., Berk, M., . . . Castle, D. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16(1), 320-1-320-9. DOI Scopus39 WoS31 Europe PMC29 |
| 2016 |
Large, M., Galletly, C., Myles, N., Ryan, C., & Myles, H. (2016). Known unknown and unknown unknowns in suicide risk assessment: what do recent meta-analyses tell us about aleatory and epistemic uncertainty?. BJ Psych Bulletin, 1-4. |
| 2016 |
Galletly, C. A. (2016). Look who's talking. Aust N Z J Psychiatry, 50(11), 1031-1032. DOI |
| 2016 |
Pillai, A., Howell, K., Ahmed, A., Weinberg, D., Allen, K., Bruggemann, J., . . . Weickert, T. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 21(5), 686-692. DOI Scopus72 WoS65 Europe PMC62 |
| 2016 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Common familial risk factors for schizophrenia and diabetes mellitus. Australian and New Zealand Journal of Psychiatry, 50(5), 488-494. DOI Scopus25 WoS22 Europe PMC18 |
| 2015 |
Happell, B., Galletly, C., Castle, D., Platania-Phung, C., Stanton, R., Scott, D., . . . Furness, T. (2015). Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care. International Journal of Mental Health Nursing, 24(5), 421-438. DOI Scopus15 WoS16 Europe PMC13 |
| 2015 |
Balzan, R., & Galletly, C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: a case study. Frontiers in Psychology, 6, 967-1-967-6. DOI Scopus14 WoS11 Europe PMC8 |
| 2015 |
Posselt, M., Procter, N., de Crespigny, C., & Galletly, C. (2015). Merging perspectives: obstacles to recovery for youth from refugee backgrounds with comorbidity. Australasian Psychiatry, 23(3), 293-299. DOI Scopus18 WoS17 Europe PMC10 |
| 2015 |
Weickert, T., Weinberg, D., Lenroot, R., Catts, S., Wells, R., Vercammen, A., . . . Weickert, C. (2015). Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Molecular Psychiatry, 20(6), 685-694. DOI Scopus122 WoS117 Europe PMC108 |
| 2015 |
Happell, B., Platania-Phung, C., Webster, S., McKenna, B., Millar, F., Stanton, R., . . . Scott, D. (2015). Applying the World Health Organization Mental Health Action Plan to evaluate policy on addressing co-occurrence of physical and mental illnesses in Australia. Australian Health Review, 39(4), 370-378. DOI Scopus12 WoS12 Europe PMC10 |
| 2015 |
Kisely, S., Chang, A., Crowe, J., Galletly, C., Jenkins, P., Loi, S., . . . Macfarlane, S. (2015). Getting started in research: Systematic reviews and meta-analyses. Australasian Psychiatry, 23(1), 16-21. DOI Scopus9 Europe PMC4 |
| 2015 |
Lacey, M., Paolini, S., Hanlon, M., Melville, J., Galletly, C., & Campbell, L. (2015). Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers. Psychiatry Research, 225(3), 723-733. DOI Scopus43 WoS43 Europe PMC31 |
| 2015 |
Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2015). How safe is repetitive Transcranial Magnetic Stimulation?. Australian and New Zealand Journal of Psychiatry, 49(5), 485. DOI Scopus7 WoS5 Europe PMC3 |
| 2015 |
Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian and New Zealand Journal of Psychiatry, 49(12), 1227. DOI Scopus22 WoS19 Europe PMC17 |
| 2015 |
Suetani, S., Gill, S., & Galletly, C. (2015). A scholarly endeavour: Some practical tips on completing the scholarly project. Australasian Psychiatry, 23(1), 29-31. DOI Scopus10 WoS10 Europe PMC9 |
| 2015 |
Galletly, C. A., Loo, C. K., Malhi, G. S., Mitchell, P. B., & Fitzgerald, P. (2015). Why repetitive transcranial magnetic stimulation should be available for treatment resistant depression. Australian and New Zealand Journal of Psychiatry, 49(2), 182-183. DOI Scopus1 WoS1 |
| 2015 |
Nenke, M., Hahn, L., Thompson, C., Liu, D., & Galletly, C. (2015). Psychosis and cardiovascular disease: Is diet the missing link?. Schizophrenia Research, 161(2-3), 465-470. DOI Scopus18 WoS16 Europe PMC12 |
| 2015 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2015). Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample. The Australian and New Zealand Journal of Psychiatry, 49(8), 714-723. DOI Scopus11 WoS8 Europe PMC11 |
| 2015 |
Cairney, I., Galletly, C., de Crespigny, C., Liu, D., Moss, J., & Procter, N. (2015). Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide. Australasian Psychiatry, 23(3), 233-235. DOI Scopus4 WoS3 Europe PMC3 |
| 2015 |
Posselt, M., Procter, N., Galletly, C., & de Crespigny, C. (2015). Aetiology of coexisting mental health and alcohol and other drug disorders: perspectives of refugee youth and service providers. Australian Psychologist, 50(2), 130-140. DOI Scopus32 WoS30 |
| 2015 |
Galletly, C. (2015). Let there be light .... Australian and New Zealand Journal of Psychiatry, 49(3), 201-202. DOI |
| 2015 |
Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2015). Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study. The Lancet Psychiatry, 2(12), 1092-1098. DOI Scopus28 WoS25 Europe PMC18 |
| 2015 |
Galletly, C. A. (2015). Making things better?. Australian and New Zealand Journal of Psychiatry, 49(11), 958-959. DOI |
| 2015 |
Galletly, C., Clarke, P., Carnell, B., & Gill, S. (2015). A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on. Australian and New Zealand Journal of Psychiatry, 49(11), 1040-1047. DOI Scopus19 WoS14 Europe PMC9 |
| 2015 |
Badcock, J., Shah, S., Mackinnon, A., Stain, H., Galletly, C., Jablensky, J., & Morgan, V. (2015). Loneliness in psychotic disorders and its association with cognitive function and symptom profile. Schizophrenia Research, 169(1-3), 268-273. DOI Scopus140 WoS129 Europe PMC108 |
| 2015 |
Galletly, C. A. (2015). ANZJP Weltanschauung. Australian and New Zealand Journal of Psychiatry, 49(8), 677-678. DOI |
| 2015 |
de Crespigny, C., Groenkjaer, M., Liu, D., Moss, J., Cairney, I., Procter, N., . . . Galletly, C. (2015). Service provider barriers to treatment and care for people with mental health and alcohol and other drug comorbidity in a metropolitan region of South Australia. Advances in Dual Diagnosis, 8(3), 120-128. DOI Scopus16 WoS17 |
| 2015 |
Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Psychosis, socioeconomic disadvantage, and health service use in South Australia: Findings from the second. Frontiers in Public Health, 3, 1-8. DOI Scopus31 Europe PMC22 |
| 2015 |
Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis. Frontiers in Psychology, 6(NOV), 1768-1-1768-8. DOI Scopus44 WoS41 Europe PMC34 |
| 2014 |
Gill, S., Clarke, P., Rigby, A., Carnell, B., & Galletly, C. (2014). Transcranial Magnetic Stimulation and psychological therapies: Considering the benefits of a combined treatment approach for depression. World Journal of Medical Research, 3(7), 46-53. |
| 2014 |
Galletly, C. A. (2014). Educating psychiatrists in the post-pharma era. Andhra Pradesh Journal of Psychological Medicine, 15(1), 10-12. |
| 2014 |
Shah, S., Mackinnon, A., Galletly, C., Carr, V., McGrath, J., Stain, H., . . . Morgan, V. (2014). Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian national survey of psychosis. Schizophrenia Research, 159(1), 20-26. DOI Scopus31 WoS30 Europe PMC27 |
| 2014 |
Morgan, V., McGrath, J., Jablensky, A., Badcock, J., Waterreus, A., Bush, R., . . . MacKinnon, A. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine, 44(10), 2163-2176. DOI Scopus170 WoS167 Europe PMC127 |
| 2014 |
Hahn, L., Galletly, C., Foley, D., Mackinnon, A., Watts, G., Castle, D., . . . Morgan, V. (2014). Inadequate fruit and vegetable intake in people with psychosis. Australian and New Zealand Journal of Psychiatry, 48(11), 1025-1035. DOI Scopus41 WoS40 Europe PMC34 |
| 2014 |
Chan, W., Batterham, P., Christensen, H., & Galletly, C. (2014). Suicide literacy, suicide stigma and help-seeking intentions in Australian medical students. Australasian Psychiatry, 22(2), 132-139. DOI Scopus97 WoS89 Europe PMC71 |
| 2014 |
Balzan, R. P., Neaves, A., Denson, L. A., Liu, D., & Galletly, C. (2014). Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?. Cognitive Neuropsychiatry, 19(6), 471-484. DOI Scopus26 WoS26 Europe PMC20 |
| 2014 |
Searle, A., Baghurst, P., van Hooff, M., Sawyer, M., Sim, M., Galletly, C., . . . McFarlane, A. (2014). Tracing the long-term legacy of childhood lead exposure: a review of three decades of the Port Pirie Cohort study. NeuroToxicology, 43, 46-56. DOI Scopus50 WoS42 Europe PMC34 |
| 2014 |
Foley, D., MacKinnon, A., Morgan, V., Watts, G., McGrath, J., Castle, D., . . . Galletly, C. (2014). Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry, 13(2), 176-183. DOI Scopus29 WoS30 Europe PMC28 |
| 2014 |
Galletly, C., Clarke, P., Paterson, T., Rigby, A., & Gill, S. (2014). Practical considerations in the use of ultrabrief ECT in clinical practice. Journal of ECT, 30(1), 10-14. DOI Scopus25 WoS20 Europe PMC16 |
| 2014 |
Posselt, M., Galletly, C., de Crespigny, C., Cairney, I., Moss, J., Liu, D., . . . Banders, A. (2014). Ethics overload: impact of excessive ethical review on comorbidity research. Mental Health and Substance Use, 7(3), 184-194. DOI Scopus6 |
| 2014 |
Posselt, M., Galletly, C., de Crespigny, C., & Procter, N. (2014). Mental health and drug and alcohol comorbidity in young people of refugee background: a review of the literature. Mental Health and Substance Use, 7(1), 19-30. DOI Scopus32 |
| 2014 |
Galletly, C. (2014). Should lithium be added to the drinking water?. Australian & New Zealand Journal of Psychiatry, 48(9), 793-794. DOI |
| 2014 |
Ashton, M., Rigby, A., & Galletly, C. (2014). Do population-wide tobacco control approaches help smokers with mental illness?. Australian & New Zealand Journal of Psychiatry, 48(2), 121-123. DOI Scopus14 WoS12 Europe PMC7 |
| 2014 |
Burton, C., Gill, S., Clarke, P., & Galletly, C. (2014). Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Archives of Women's Mental Health, 17(3), 247-250. DOI Scopus16 WoS13 Europe PMC10 |
| 2014 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2014). Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single module programme. Australian and New Zealand Journal of Psychiatry, 48(12), 1126-1136. DOI Scopus54 WoS49 Europe PMC38 |
| 2014 |
Hahn, L., Rigby, A., & Galletly, C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Australian and New Zealand Journal of Psychiatry, 48(1), 70-79. DOI Scopus20 WoS19 Europe PMC18 |
| 2013 |
Galletly, C. (2013). When the body attacks the brain. Australian and New Zealand Journal of Psychiatry, 47(12), 1099-1100. DOI |
| 2013 |
Tidswell, J., Kleinig, T., Ash, D., Thompson, P., & Galletly, C. (2013). Early recognition of anti-N-methyl D-aspartate (Nmda) receptor encephalitis presenting as acute psychosis. Australasian Psychiatry, 21(6), 596-599. DOI Scopus12 WoS10 Europe PMC10 |
| 2013 |
Galletly, C., & Rigby, A. (2013). An overview of cognitive remediation therapy for people with severe mental illness. ISRN Rehabilitation, 2013, 1-6. DOI |
| 2013 |
McFarlane, A., Searle, A., Van Hooff, M., Baghurst, P., Sawyer, M., Galletly, C., . . . Clark, L. (2013). Prospective associations between childhood low-level lead exposure and adult mental health problems: The port pirie cohort study. Neurotoxicology, 39, 11-17. DOI Scopus32 WoS33 Europe PMC24 |
| 2013 |
Galletly, C. (2013). Sunshine, supplements, CBT and more. Australian and New Zealand Journal of Psychiatry, 47(3), 199-200. DOI |
| 2013 |
Altree, T., & Galletly, C. (2013). Laxative use and altered drug absorption. Australian and New Zealand Journal of Psychiatry, 47(7), 686. DOI Scopus3 WoS2 Europe PMC1 |
| 2013 |
Ashton, M., Rigby, A., & Galletly, C. (2013). What do 1000 smokers with mental illness say about their tobacco use?. Australian and New Zealand Journal of Psychiatry, 47(7), 631-636. DOI Scopus34 WoS30 Europe PMC26 |
| 2013 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Illusory correlations and control across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Journal of Nervous and Mental Disease, 201(4), 319-327. DOI Scopus25 WoS23 Europe PMC18 |
| 2013 |
Ashton, M., Mulconray, S., Weston, M., Rigby, A., & Galletly, C. (2013). Peer workers' role in smoking-cessation groups for people with mental illness. Australasian Psychiatry, 21(3), 246-248. DOI Scopus5 WoS7 Europe PMC7 |
| 2013 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Confirmation biases across the psychosis continuum: The contribution of hypersalient evidence-hypothesis matches. British Journal of Clinical Psychology, 52(1), 53-69. DOI Scopus55 WoS53 Europe PMC39 |
| 2013 |
Ashton, M., Rigby, A., & Galletly, C. (2013). Evaluation of a community-based smoking cessation programme for people with severe mental illness. Tobacco Control, 24(3), 275-280. DOI Scopus21 WoS20 Europe PMC14 |
| 2013 |
Foley, D., Mackinnon, A., Watts, G., Shaw, J., Magliano, D., Castle, D., . . . Galletly, C. (2013). Cardiometabolic risk Indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One, 8(12), 1-8. DOI Scopus40 WoS40 Europe PMC35 |
| 2012 |
Hall, T., Galletly, C., Clark, C., Veltmeyer, M., Metzger, L., Gilbertson, M., . . . McFarlane, A. (2012). The relationship between Hippocampal asymmetry and working memory processing in combat-related PTSD: a monozygotic twin study. Biology of Mood & Anxiety Disorders, 2(21), 1-8. DOI Europe PMC7 |
| 2012 |
Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2012). Evaluating health literacy in people with mental illness using the Test of Functional Health Literacy in Adults. Nursing Outlook, 60(5), 316-321. DOI Scopus20 WoS19 Europe PMC14 |
| 2012 |
Campbell, L., Hanlon, M., Poon, A., Paolini, S., Stone, M., Galletly, C., . . . Cohen, M. (2012). The experiences of Australian parents with psychosis: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 890-900. DOI Scopus65 WoS58 Europe PMC37 |
| 2012 |
Stain, H., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 879-889. DOI Scopus151 WoS139 Europe PMC104 |
| 2012 |
Moore, E., Mancuso, S., Slade, T., Galletly, C., & Castle, D. (2012). The impact of alcohol and illicit drugs on people with psychosis: the Second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 864-878. DOI Scopus64 WoS58 Europe PMC45 |
| 2012 |
Cooper, J., Mancuso, S., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 851-863. DOI Scopus145 WoS136 Europe PMC115 |
| 2012 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Reasoning heuristics across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Cognitive Neuropsychiatry, 17(5), 431-450. DOI Scopus29 WoS28 Europe PMC20 |
| 2012 |
Waterreus, A., Morgan, V., Castle, D., Galletly, C., Jablensky, A., Di Prinzio, P., & Shah, S. (2012). Medication for psychosis - consumption and consequences: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 762-773. DOI Scopus52 WoS50 Europe PMC46 |
| 2012 |
Galletly, C., Foley, D., Waterreus, A., Watts, G., Castle, D., McGrath, J., . . . Morgan, V. (2012). Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 753-761. DOI Scopus176 WoS167 Europe PMC141 |
| 2012 |
Waghorn, G., Saha, S., Harvey, C., Morgan, V., Waterreus, A., Bush, R., . . . McGrath, J. (2012). 'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 774-785. DOI Scopus110 WoS103 Europe PMC79 |
| 2012 |
Morgan, V., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J., Carr, V., . . . Saw, S. (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 735-752. DOI Scopus435 WoS363 Europe PMC341 |
| 2012 |
Ash, D., Singh, T., Air, T., Burton, C., & Galletly, C. (2012). Metabolic health of people admitted to a psychiatric intensive care unit in Adelaide, South Australia. Primary Care Companion to the Journal of Clinical Psychiatry, 14(1), 1-2. DOI |
| 2012 |
Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Over-adjustment or miscomprehension? A re-examination of the jumping to conclusions bias. Australian and New Zealand Journal of Psychiatry, 46(6), 532-540. DOI Scopus68 WoS69 Europe PMC56 |
| 2012 |
Balzan, R., Delfabbro, P., & Galletly, C. (2012). Delusion-proneness or miscomprehension? A re-examination of the jumping-to-conclusions bias. Australian Journal of Psychology, 64(2), 100-107. DOI Scopus22 WoS25 |
| 2012 |
Kelly, D., Gill, S., Clarke, P., Burton, C., & Galletly, C. (2012). Delayed response to repetitive transcranial magnetic stimulation treatment for intractable auditory hallucinations in schizoaffective disorder. Annals of Clinical Psychiatry, 24(2), 172-173. DOI Scopus4 WoS1 Europe PMC1 |
| 2012 |
Forbes, F., Galletly, C., Liu, D., Tyllis, P., & Clark, C. (2012). Assessing cognition in schizophrenia: a comparison of clinician and computerized test administration. Applied Neuropsychology, 19(0001), 9-15. DOI Scopus4 WoS3 Europe PMC4 |
| 2012 |
Galletly, C., Paterson, T., & Burton, C. (2012). A report on the introduction of ultrabrief pulse width ECT in a private psychiatric hospital. Journal of ECT, 28(1), 59. DOI Scopus12 WoS10 Europe PMC4 |
| 2012 |
Galletly, C., Gill, S., Clarke, P., Burton, C., & Fitzgerald, P. (2012). A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments?. Psychological Medicine, 42(5), 981-988. DOI Scopus46 WoS41 Europe PMC39 |
| 2012 |
Galletly, C. (2012). Debates, disputes, discussions and deliberations. Australian and New Zealand Journal of Psychiatry, 46(10), 917-918. DOI |
| 2012 |
Dawson, S., Kettler, L., Burton, C., & Galletly, C. (2012). Do people with schizophrenia lack emotional intelligence?. Schizophrenia Research and Treatment, Online, 1-8. DOI WoS15 Europe PMC12 |
| 2012 |
Silverstein, S., All, S., Thompson, J., Williams, L., Whitford, T., Nagy, M., . . . Gordon, E. (2012). Absolute level of gamma synchrony is increased in first-episode schizophrenia during face processing. Journal of Experimental Psychopathology, 3(4), 702-723. DOI Scopus5 WoS5 |
| 2012 |
Galletly, C. (2012). People living with psychosis: the good news and the bad news. Australian and New Zealand Journal of Psychiatry, 46(9), 803-807. DOI Scopus6 WoS4 Europe PMC4 |
| 2012 |
Galletly, C., Clark, L., Van Hooff, M., & McFarlane, A. (2012). CHILDHOOD TRAUMA AND SUBCLINICAL PSYCHOTIC EXPERIENCES IN YOUNG ADULTHOOD: 20-YEAR LONGITUDINAL ANALYSES OF TWO COHORT STUDIES. SCHIZOPHRENIA RESEARCH, 136, S63-S64. DOI WoS1 |
| 2012 |
Galletly, C. A., de Crespigny, C., Athanasos, P., Moss, J., Proctor, N., Banders, A., . . . Francis, H. (2012). COMORBIDITY ACTION RESEARCH IN NORTHERN ADELAIDE, SOUTH AUSTRALIA. SCHIZOPHRENIA RESEARCH, 136, S276. DOI |
| 2012 |
Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G. F., Castle, D., McGrath, J., . . . Morgan, V. A. (2012). HIGH RATES OF CARDIOMETABOLIC RISK FACTORS IN PEOPLE WITH PSYCHOTIC DISORDERS. SCHIZOPHRENIA RESEARCH, 136, S308. DOI |
| 2011 |
Galletly, C. A. (2011). Differential diagnosis of Tardive Dyskinesia in an elderly woman taking antipsychotic medication. Annals of Clinical Psychiatry, 23(4), 308-309. |
| 2011 |
Galletly, C., Van Hooff, M., & McFarlane, A. (2011). PSYCHOTIC SYMPTOMS IN YOUNG ADULTS EXPOSED TO BUSHFIRES DURING CHILDHOOD - A 20 YEAR FOLLOW-UP STUDY. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 45, A34. |
| 2011 |
Galletly, C., Van Hooff, M., & McFarlane, A. (2011). Psychotic symptoms in young adults exposed to childhood trauma - A 20 year follow-up study. Schizophrenia Research, 127(1-3), 76-82. DOI Scopus54 WoS54 Europe PMC42 |
| 2011 |
Galletly, C., Bell, S., Burton, C., & Turnbull, C. (2011). Bed accessibility in a private psychiatric hospital. Australasian Psychiatry, 19(2), 160-162. DOI Scopus2 WoS2 |
| 2011 |
Galletly, C., & Burton, C. (2011). Improving medical student attitudes towards people with schizophrenia. Australian and New Zealand Journal of Psychiatry, 45(6), 473-476. DOI Scopus57 WoS54 Europe PMC35 |
| 2011 |
Galletly, C. (2011). ANZJP This Month. Australian and New Zealand Journal of Psychiatry, 45(12), 1015-1016. DOI |
| 2011 |
Crismani, C., & Galletly, C. (2011). 'Walk-ins': Developing a nursing role to manage unscheduled presentations to a community mental health clinic. Contemporary Nurse, 39(1), 12-19. DOI Scopus2 WoS2 Europe PMC1 |
| 2011 |
Galletly, C., & Crichton, J. (2011). Accomplishments of the thought disordered person: A case study in psychiatrist-patient interaction. Medical Hypotheses, 77(5), 900-904. DOI Scopus4 WoS3 Europe PMC1 |
| 2010 |
Singh, R., Rowan, J., Burton, C., & Galletly, C. (2010). How effective is a hospital at home service for people with acute mental illness?. Australasian Psychiatry, 18(6), 512-516. DOI Scopus12 WoS15 Europe PMC8 |
| 2010 |
Galletly, C., Fitzgerald, P., Clarke, P., Gill, S., Burton, C., & Turnbull, C. (2010). A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service. Australasian Psychiatry, 18(4), 314-317. DOI Scopus8 WoS8 Europe PMC7 |
| 2010 |
Galletly, C. A. (2010). Ask patients about their internet use. Medical Journal of Australia, 193(5), 312. DOI Scopus2 WoS1 Europe PMC1 |
| 2009 |
Ash, D., & Galletly, C. (2009). Challenges in psychiatric classification: The case of generalized anxiety disorder. Australasian Psychiatry, 17(6), 484-487. DOI Scopus1 |
| 2009 |
Galletly, C., Chur-Hansen, A., Air, T., & Chapman, I. (2009). Academics of the future? A survey of final year medical students. Australasian Psychiatry, 17(6), 502-505. DOI Scopus10 WoS9 Europe PMC9 |
| 2009 |
Harvey, K., Galletly, C., Field, C., & Proeve, M. (2009). The effects of verbalisation on cognitive performance in schizophrenia: A pilot study using tasks from Delis Kaplan Executive Function System. Neuropsychological Rehabilitation, 19(5), 733-741. DOI Scopus12 WoS10 Europe PMC9 |
| 2009 |
Alexander, D., Flynn, G., Wong, W., Whitford, T., Harris, A., Galletly, C., & Silverstein, S. (2009). Spatio-temporal EEG waves in first episode schizophrenia. Clinical Neurophysiology, 120(9), 1667-1682. DOI Scopus27 WoS27 Europe PMC27 |
| 2009 |
Clark, C., Galletly, C., Ash, D., Moores, K., Penrose, R., & McFarlane, A. (2009). Evidence-based medicine evaluation of electrophysiological studies of the anxiety disorders. Clinical EEG and Neuroscience, 40(2), 84-112. DOI Scopus58 WoS46 Europe PMC38 |
| 2009 |
Galletly, C. (2009). Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology, 202(1-3), 259-273. DOI Scopus43 WoS30 Europe PMC28 |
| 2009 |
Galletly, C., & Burton, C. (2009). The effects of experiencing simulated auditory hallucinations on attitudes to schizophrenia in final year medical students. Proceedings of 2nd Biennial Schizophrenia International Research Conference, 117(2-3), 402-403. DOI WoS1 |
| 2008 |
Flynn, G., Alexander, D., Harris, A., Whitford, T., Wong, W., Galletly, C., . . . Williams, L. (2008). Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophrenia Research, 105(1-3), 262-271. DOI Scopus63 WoS59 Europe PMC50 |
| 2008 |
Nestor, P., & Galletly, C. (2008). The employment of consumers in mental health services: politically correct tokenism or genuinely useful?. Australasian Psychiatry, 16(5), 344-347. DOI Scopus29 WoS28 Europe PMC20 |
| 2008 |
Savilla, K., Kettler, L., & Galletly, C. (2008). Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Australian and New Zealand Journal of Psychiatry, 42(6), 496-504. DOI Scopus101 WoS87 Europe PMC75 |
| 2008 |
Galletly, C., McFarlane, A., & Clark, C. (2008). Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder. Psychiatry Research, 159(1-2), 196-206. DOI Scopus9 WoS9 Europe PMC10 |
| 2008 |
Williams, L., Whitford, T., Flynn, G., Wong, W., Liddell, B., Silverstein, S., . . . Gordon, E. (2008). General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro, test battery. Schizophrenia Research, 99(1-3), 182-191. DOI Scopus97 WoS82 Europe PMC73 |
| 2008 |
Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Does antenatal screening for psychosocial risk factors predict postnatal depression? A follow-up study of 154 women in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 51-55. DOI Scopus47 WoS42 Europe PMC37 |
| 2008 |
Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Antenatal psychosocial risk factors and depression amoung women living in socioeconomically disadvantaged suburbs in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 45-50. DOI Scopus53 WoS47 Europe PMC43 |
| 2008 |
Keks, N., Galletly, C. A., Hope, J., & Hustig, H. (2008). Management of acute psychosis in an emergency setting. Advances in Schizophrenia and Clinical Psychiatry, 3, 78`-83. |
| 2007 |
Galletly, C. A., McFarlane, A. C., & Clark, C. R. (2007). Erratum to "Impaired updating of working memory in schizophrenia" [International Journal of Psychophysiology 63 (2007) 265-274] (DOI:10.1016/j.ijpsycho.2006.11.004). International Journal of Psychophysiology, 66(3), 271. DOI |
| 2007 |
Plevin, D., Galletly, C., & Roughan, P. (2007). Sexual dysfunction in men treated with depot antipsychotic drugs: A pilot study. Sexual Health, 4(4), 269-271. DOI Scopus6 WoS7 Europe PMC3 |
| 2007 |
Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007). Psychological benefits of a high-protein low-carbohydrate diet in obese women with polycystic ovary syndrome - A pilot study. Appetite, 49(3), 590-593. DOI Scopus86 WoS74 Europe PMC66 |
| 2007 |
Galletly, C., McFarlane, A., & Clark, C. (2007). Impaired updating of working memory in schizophrenia. International Journal of Psychophysiology, 63(3), 265-274. DOI Scopus28 WoS24 Europe PMC18 |
| 2006 |
Galletly, C., & Watson, D. (2006). Substance misuse in patients with acute mental illness. Medical Journal of Australia, 184(12), 645. DOI Scopus1 WoS1 Europe PMC1 |
| 2006 |
Brown, K., Alexander, D., Boord, P., Das, P., Flynn, G., Galletly, C., . . . Williams, L. (2006). Reduced fMRI activity in response to salient stimuli in first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 279-280. DOI |
| 2006 |
Galletly, C., Proeve, M., Field, C., & Harvey, K. (2006). Silence is golden? Improving cognitive performance in schizophrenia.. Acta neuropsychiatrica, 18(6), 251. DOI |
| 2006 |
Das, P., Alexander, D., Boord, P., Brown, K., Flynn, G., Galletly, C., . . . Wong, W. (2006). Impaired connectivity in amygdala pathways may explain disorganization symptoms of patients with first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 282. DOI Europe PMC1 |
| 2006 |
Alexander, D., Boord, P., Brown, K., Das, P., Flynn, G., Galletly, C., . . . Wong, W. (2006). First-episode psychosis and direction of wave propagation at 1 Hz in the EEG.. Acta neuropsychiatrica, 18(6), 240. DOI Europe PMC3 |
| 2005 |
Galletly, C., Clark, C., & McFarlane, A. (2005). Clozapine improves working memory updating in schizophrenia. European Neuropsychopharmacology, 15(6), 601-608. DOI Scopus17 WoS15 Europe PMC13 |
| 2004 |
Galletly, C. (2004). Crossing professional boundaries in medicine: the slippery slope to patient sexual exploitation. Medical Journal of Australia, 181(7), 380-383. DOI Scopus55 WoS44 Europe PMC24 |
| 2004 |
Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2004). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Journal of Clinical Endocrinology and Metabolism, 89(7), 3337-3344. DOI Scopus150 WoS121 Europe PMC100 |
| 2004 |
Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., Galletly, C., & Norman, R. J. (2004). Erratum: Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome (Journal of Clinical Endocrinology and Metabolism (2003) 88 (812-819)). Journal of Clinical Endocrinology and Metabolism, 89(5), 2337. |
| 2003 |
Ash, D., Galletly, C., Haynes, J., & Braben, P. (2003). Violence, self-harm, victimisation and homelessness in patients admitted to an acute inpatient unit in South Australia. International Journal of Social Psychiatry, 49(2), 112-118. DOI Scopus19 Europe PMC14 |
| 2003 |
Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2003). Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(2), 812-819. DOI Scopus448 WoS360 Europe PMC290 |
| 2001 |
Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2001). Working memory in posttraumatic stress disorder - An event-related potential study. Journal of Traumatic Stress, 14(2), 295-309. DOI Scopus73 WoS64 Europe PMC56 |
| 2000 |
Comley, C., Galletly, C., & Ash, D. (2000). The use of atropine eye drops for clozapine induced hypersalivation. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. DOI |
| 2000 |
Galletly, C. (2000). Psychiatry and fertility services. Australasian Psychiatry, 8(3), 264-266. |
| 2000 |
Galletly, C., Clark, C., & McFarlane, A. (2000). Treating cognitive dysfunction in patients with schizophrenia. Journal of Psychiatry & Neuroscience, 25(2), 117-124. Scopus19 WoS19 Europe PMC14 |
| 2000 |
Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (2000). The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Progress in Neuro Psychopharmacology and Biological Psychiatry, 24(8), 1329-1338. DOI Scopus26 WoS24 Europe PMC16 |
| 2000 |
Galletly, C. (2000). Correspondence. Australasian Psychiatry, 8(3), 264-265. DOI |
| 2000 |
Comley, C., Galletly, C., & Ash, D. (2000). Use of atropine eye drops for clozapine induced hypersalivation [5]. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. DOI Scopus43 Europe PMC29 |
| 1999 |
Galletly, C. (1999). Prescribing of psychotropic drugs in an acute inpatient unit. Australian and New Zealand Journal of Psychiatry, 33(2), 181-182. DOI Scopus5 Europe PMC3 |
| 1999 |
Galletly, C., Clark, C., McFarlane, A., & Weber, D. (1999). Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia. Psychiatric Services, 50(1), 101-103. DOI Scopus16 WoS13 Europe PMC12 |
| 1999 |
Ash, D., Galletly, C., Kinneally, J., & Braben, P. (1999). Self-Reported Forensic Histories Among Patients Admitted to an Acute Psychiatric Unit. Psychiatry, Psychology and Law, 6(2), 197-202. DOI Scopus1 |
| 1998 |
Clark, A., Thornley, B., Tomlinson, L., Galletly, C., & Norman, R. (1998). Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction, 13(6), 1502-1505. DOI Scopus628 WoS492 Europe PMC365 |
| 1998 |
Galletly, C., & Whyte, F. (1998). Epidemiology of prostate cancer in two European countries: Scotland and Norway. European Journal of Cancer Care, 7(4), 240-246. DOI |
| 1997 |
Galletly, C. (1997). Borderline-dissociation comorbidity [8]. American Journal of Psychiatry, 154(11), 1629. DOI Scopus7 Europe PMC2 |
| 1997 |
Galletly, C. A., & Tsourtos, G. (1997). Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. DOI Scopus12 Europe PMC9 |
| 1997 |
Galletly, C. A. (1997). Dissociation and PTSD. American Journal of Psychiatry, 154, 1629. |
| 1997 |
Field, C., Galletly, C., Anderson, D., & Walker, P. (1997). Computer aided cognitive rehabilitation possible application to the attentional deficit of schizophrenia, a report of negative results. Perceptual and Motor Skills, 85(3, part 1), 995-1002. DOI Scopus32 Europe PMC18 |
| 1997 |
Galletly, C., Clark, R., McFarlane, A., & Lueber, D. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine.. Psychiatry Research, 72, 159-161. |
| 1997 |
Galletly, C. (1997). Clinical rating scales for substance abuse. Psychiatric Services, 48(1), 105-106. DOI |
| 1997 |
Galletly, C., & Tsourtos, G. (1997). Antipsychotic drug doses in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. DOI |
| 1997 |
Galletly, C. (1997). Borderline-Dissociation Comorbidity. American Journal of Psychiatry, 154, 629. |
| 1997 |
Ash, D., & Galletly, C. (1997). Crisis beds: The interface between the hospital and the community. International Journal of Social Psychiatry, 43(3), 193-198. DOI Scopus8 Europe PMC5 |
| 1997 |
Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Research, 72(3), 161-166. DOI Scopus108 WoS91 Europe PMC72 |
| 1996 |
Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders. BRITISH JOURNAL OF PSYCHIATRY, 169(6), 793-794. DOI WoS1 Europe PMC1 |
| 1996 |
118. McFarlane, A. C., Clark, C. R., Weber, D., & Galletly, C. A. (1996). Biological paradigms of the attentional processing in post traumatic stress disorder. European Neuropsychopharmacology, 6, 80. |
| 1996 |
Galletly, C., Clark, A., & Tomlinson, L. (1996). Evaluation of dexfenfluramine in a weight loss program for obese infertile women.. International Journal of Eating Disorders, 19(2), 209-212. DOI Scopus11 Europe PMC6 |
| 1996 |
Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). Improved pregnancy rates for obese, infertile women following a group treatment program: an open pilot study. General Hospital Psychiatry, 18(3), 192-195. DOI Scopus51 Europe PMC24 |
| 1996 |
Galletly, C. (1996). Comment on "Sexual Abuse in therapy : gender issues.". Australian and New Zealand Journal of Psychiatry, 30, 132-133. |
| 1996 |
Galletly, C. (1996). Subjective muscle weakness and hypotnoia during Clozapine treatment. Annals of Clinical Psychiatry, 8(4), 189-192. DOI Scopus7 Europe PMC6 |
| 1996 |
Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). A group program for obese, infertile women: weight loss and improved psychological health. Journal of Psychosomatic Obstetrics and Gynaecology, 17(2), 125-128. DOI Scopus39 Europe PMC25 |
| 1996 |
Galletly, C., Clark, C., & McFarlane, A. (1996). Artificial Neural Networks: A prospective tool for the analysis of psychiatric disorders.. Journal of Psychiatry and Neuroscience, 21(4), 239-247. Scopus14 WoS10 Europe PMC5 |
| 1996 |
Galletly, C., Wilson, D., & McEwen, S. (1996). Eosiniphilia associated with decreasing neutrophil count in a Clozapine-treated patient.. Journal of Clinical Psychiatry, 57, 40-41. Scopus4 Europe PMC28 |
| 1996 |
Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders.. British Journal of Psychiatry the Journal of Mental Science, 169(6), 793-794. DOI Scopus1 |
| 1996 |
Galletly, C. (1996). Comment. Australian and New Zealand Journal of Psychiatry, 30(1), 132-133. DOI |
| 1995 |
Clark, A., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. (1995). Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction, 10(10), 2705-2712. DOI Scopus558 WoS405 Europe PMC292 |
| 1995 |
Galletly, C. A., Schrader, G. D., Chestemtan, H. M., & Tsourtos, G. (1995). Medical student attitudes to psychiatry: lack of effect of psychiatric hospital experience. Medical Education, 29(6), 449-451. DOI Scopus44 WoS34 Europe PMC20 |
| 1993 |
123. Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, R. (1993). A review of the efficacy of low-dose antipsychotic medication in the treatment of schizophrenia. Schizophrenia Bulletin, 19, 155-164. |
| 1993 |
Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, C. R. (1993). Low-dose depot medication in schizophrenia. Schizophrenia Bulletin, 19(1), 155-164. DOI Scopus15 WoS17 Europe PMC9 |
| 1993 |
Galletly, C. A. (1993). Psychiatrist-patient sexual relationships: The ethical dilemmas. Australasian Psychiatry, 27(1), 133-139. DOI Scopus17 WoS14 Europe PMC11 |
| 1993 |
Galletly, C. A., Field, C. D., & Prior, M. (1993). Urine drug screening of patients admitted to a state psychiatric hospital. Hospital and Community Psychiatry, 44(6), 587-589. DOI Scopus28 WoS25 Europe PMC15 |
| 1992 |
Galletly, C. A. (1992). Antipsychotic drug doses in a schizophrenia inpatient unit. Australian and New Zealand Journal of Psychiatry, 26(4), 574-576. DOI Scopus17 WoS15 Europe PMC8 |
| 1991 |
Galletly, C. A., Field, C. D., & Ormond, C. L. (1991). Changing patterns of electroconvulsive therapy use: Results of a five-year survey. Australian and New Zealand Journal of Psychiatry, 25(4), 535-540. DOI Scopus9 WoS9 Europe PMC7 |
| 1991 |
Galletly, C. A. (1991). A review of antipsychotic drug doses.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 11, 74-76. |
| 1987 |
Galletly, C. A., Field, C., & Ormond, C. (1987). An audit of electroconvulsive therapy.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 7(27), 171-174. Scopus1 Europe PMC1 |
| 1987 |
Galletly, C. A., & Field, C. D. (1987). Learning and memory impairment with benzhexol. Australian and New Zealand Journal of Psychiatry, 21(4), 612-614. DOI Scopus4 WoS5 Europe PMC3 |
| 1985 |
Galletly, C. A., Morris, H., & Newcombe, A. (1985). The dexamethasone suppression test in elderly, non-depressed patients with dementia. Australian and New Zealand Journal of Psychiatry, 19(1), 95-96. DOI Scopus3 WoS2 Europe PMC3 |
| 1983 |
131. Morris, H. A., Gilliland, J. M., Berriman, H. E., & Galletly, C. A. (1983). Assessment of the dexamethasone suppression test of endogenous depression. Clinical Biochemical Research, 4, 82. |
| 1982 |
Manley, D., & Galletly, C. A. (1982). Survey of children and their families presenting at a child psychiatric service. New Zealand Medical Journal, 95(718), 732-734. |
| 1982 |
James, B., & Galletly, C. A. (1982). The psychiatric contribution to general medical education: Some problems of generalization. Medical Education, 16(3), 147-150. DOI Scopus1 Europe PMC1 |
| 1979 |
Franzcp, B. J., & Galletly, C. A. (1979). Case notes as indicators of the prevailing medical model: Implications. New Zealand Medical Journal, 90(648), 427-431. |
| 1979 |
Galletly, C., & James, B. (1979). Anorexia nervosa in a male: Comment and illustration. New Zealand Medical Journal, 89(631), 171-173. Scopus2 Europe PMC1 |
| - |
Galletly, C. (2014). Role of cognitive enhancement in schizophrenia. Neuroscience and Neuroeconomics, 75. DOI |